Dasatinib and Quercetin Limit Gingival Senescence, Inflammation, and Bone Loss.

ABSTRACT: Cellular senescence has emerged as one of the central hallmarks of aging and drivers of chronic comorbidities, including periodontal diseases. Senescence can also occur in younger tissues and instigate metabolic alterations and dysfunction, culminating in accelerated aging and pathological consequences. Senotherapeutics, such as the combination of dasatinib and quercetin (DQ), are being increasingly used to improve the clinical outcomes of chronic disorders and promote a healthy life span through the reduction of senescent cell burden and senescence-associated secretory phenotype (SASP). Recent evidence suggests that senescent cells and SASP can contribute to the pathogenesis of periodontal diseases as well. In this study, we investigated the effect of DQ interventions on periodontal tissu

SUBMITTER: Rattanaprukskul K 

PROVIDER: S-EPMC11909784 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature